Table 3.
Secondary outcomes
| Outcome | Number of studies | Number of patients | Odds ratio (95% CI), P | Within-group heterogeneity (I2) |
|---|---|---|---|---|
| Diagnostic accuracy | ||||
| Overall | 5 | FNB + ROSE: 912 FNB: 917 |
2.49 (1.08-5.73) 0.03 |
74% |
| End-cutting needles | 2 | FNB + ROSE: 630 FNB: 465 |
0.71 (0.29-3.61) 0.56 |
16% |
| Reverse bevel needles | 3 | FNB + ROSE: 282 FNB: 452 |
3.24 (1.19-8.82) 0.02 |
25% |
| Diagnostic sensitivity | 3 | FNB + ROSE: 899 FNB: 907 |
1.94 (0.84-4.49) 0.12 |
77% |
|
| ||||
| Outcome | Number of studies | Number of patients | Mean difference (95% CI), P | Within-group heterogeneity (I2) |
|
| ||||
| Number of needle passes | 5 | FNB + ROSE: 758 FNB: 851 |
0.07 (−0.22-0.37) 0.62 |
79% |
FNB: Fine-needle biopsy; ROSE: Rapid on-site evaluation, CI: Confidence interval